Incyte finalizes the acquisition of Escient Pharmaceuticals

Incyte Completes Acquisition of Escient Pharmaceuticals

Incyte yesterday announced that it has completed its acquisition of Escient Pharmaceuticals, a clinical-stage drug discovery and development company advancing novel small molecule therapeutics for systemic immune and neuro-immune disorders. “The acquisition of Escient and its first-in-class oral MRGPR antagonists bolsters our Inflammation and Autoimmunity portfolio and our commitment to creating innovative solutions that address […]